Quality of life in patients undergoing repetitive TACE for the treatment of intermediate stage HCC

Volume: 144, Issue: 10, Pages: 1991 - 1999
Published: Jul 14, 2018
Abstract
With a limited overall survival (OS) of 20 months in patients diagnosed with intermediate stage hepatocellular carcinoma (HCC), the preservation of quality of life (QoL) during transarterial chemoembolization (TACE) procedures remains a primary goal. The aim of our study was to evaluate the change in QoL amongst patients undergoing repetitive TACE and to identify specific risk factors that may predict change in QoL. QoL was assessed in 82...
Paper Details
Title
Quality of life in patients undergoing repetitive TACE for the treatment of intermediate stage HCC
Published Date
Jul 14, 2018
Volume
144
Issue
10
Pages
1991 - 1999
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.